8-K
Current Report
ELITE PHARMACEUTICALS INC /NV/ Filed Acc 0001144204-12-001383
Shareholder rights changed
- Item 3.03 Material modification to rights of security holders
From the SEC's structured data for this filing
Loading v245005_8k.htm…